PALI

PALI

Palisade Bio Inc

Palisade Bio, Inc. develops oral phosphodiesterase-4 inhibitor prodrugs targeting inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. Its lead candidate, PALI-2108, is undergoing clinical trials to assess safety and efficacy.

โš•๏ธ Healthcare NASDAQ Listed 2006 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth-90.34%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-20.01%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-51.56%
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency
All Time
Score
Net Growth-8x
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend29%
Revenue Consistency

See the full market ranking โ†’

Palisade Bio Inc fundamental performance

Between 2015 and 2025, revenue declined from $ 10.42K to $ 0.00 and net income went from -$ 20M to -$ 16M. Revenue increased in 2 of those 10 years; net income in 4.

Across Palisade Bio Inc's full reported history, from 2006 to 2025, revenue declined from $ 265.76K to $ 0.00 and net income went from -$ 3M to -$ 16M. Revenue increased in 29% of the years measured; net income in 40%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.96โ€”
1 Year2025-08-12
$ 0.75161.33%
5 Years2021-08-12
$ 2.04K-99.90%
10 Years2016-08-12
$ 234K-100.00%
All Time2006-12-20
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 31M$ 125M
2025$ 0.00-$ 16M$ 133M
2024$ 0.00-$ 14M$ 9M
2023$ 250K-$ 12M$ 12M
2022$ 250K-$ 14M$ 12M
2021$ 0.00-$ 26M$ 10M
2020$ 13.52K-$ 10M$ 729K
2019$ 15.39K-$ 8M$ 5M
2018$ 260K-$ 4M$ 5M
2017$ 260K-$ 15M$ 11M
2016$ 16.25K-$ 21M$ 20M
2015$ 10.42K-$ 20M$ 12M
2014$ 18.83K-$ 22M$ 27M
2013$ 110K-$ 19M$ 16M
2012$ 407.71K-$ 10M$ 7M
2011$ 390.63K-$ 12M$ 2M
2010$ 733.44K-$ 18M$ 9M
2009-$ 10M$ 2M
2008-$ 11M$ 4M
2007$ 306.06K-$ 7M$ 7M
IPO2006$ 265.76K-$ 3M$ 1M

Explore beyond PALI

You're looking at Palisade Bio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies